Concepts (231)
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
| Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Heart Rate | 35 | 2018 | 266 | 2.970 |
Why?
|
| Anemia, Sickle Cell | 3 | 2026 | 187 | 1.430 |
Why?
|
| Blood Pressure | 13 | 2015 | 666 | 0.980 |
Why?
|
| Internal-External Control | 1 | 2026 | 63 | 0.930 |
Why?
|
| Mental Health Services | 1 | 2026 | 141 | 0.830 |
Why?
|
| Patient Acceptance of Health Care | 1 | 2026 | 497 | 0.680 |
Why?
|
| Stress, Psychological | 11 | 2017 | 661 | 0.670 |
Why?
|
| Electrocardiography | 13 | 2017 | 185 | 0.640 |
Why?
|
| Biofeedback, Psychology | 1 | 2018 | 5 | 0.580 |
Why?
|
| Laughter | 1 | 2018 | 1 | 0.560 |
Why?
|
| Diagnosis, Computer-Assisted | 3 | 2007 | 22 | 0.530 |
Why?
|
| Vagus Nerve | 6 | 2017 | 21 | 0.520 |
Why?
|
| Autonomic Nervous System | 8 | 2017 | 39 | 0.450 |
Why?
|
| Aging | 5 | 2009 | 783 | 0.420 |
Why?
|
| Emotions | 5 | 2016 | 254 | 0.420 |
Why?
|
| Adult | 33 | 2026 | 13872 | 0.410 |
Why?
|
| Young Adult | 16 | 2026 | 5080 | 0.400 |
Why?
|
| Depression | 2 | 2018 | 863 | 0.390 |
Why?
|
| Female | 38 | 2026 | 24698 | 0.380 |
Why?
|
| Models, Cardiovascular | 4 | 2007 | 98 | 0.360 |
Why?
|
| Heart | 8 | 2016 | 184 | 0.350 |
Why?
|
| Male | 36 | 2026 | 23409 | 0.350 |
Why?
|
| Anxiety | 1 | 2018 | 874 | 0.330 |
Why?
|
| Humans | 47 | 2026 | 43102 | 0.320 |
Why?
|
| Blood Pressure Determination | 3 | 2011 | 54 | 0.300 |
Why?
|
| Cardiovascular System | 2 | 2006 | 37 | 0.290 |
Why?
|
| Middle Aged | 22 | 2026 | 12222 | 0.290 |
Why?
|
| Signal Processing, Computer-Assisted | 4 | 2004 | 66 | 0.290 |
Why?
|
| Adolescent | 18 | 2018 | 6081 | 0.280 |
Why?
|
| Sex Factors | 6 | 2015 | 1028 | 0.260 |
Why?
|
| Amobarbital | 2 | 2008 | 2 | 0.260 |
Why?
|
| Hydrocortisone | 4 | 2014 | 93 | 0.250 |
Why?
|
| Arrhythmias, Cardiac | 1 | 2007 | 42 | 0.250 |
Why?
|
| Prejudice | 2 | 2006 | 116 | 0.240 |
Why?
|
| Electroencephalography | 2 | 2018 | 139 | 0.240 |
Why?
|
| Pulsatile Flow | 1 | 2006 | 28 | 0.240 |
Why?
|
| Social Perception | 1 | 2006 | 72 | 0.230 |
Why?
|
| Stroke Volume | 1 | 2006 | 122 | 0.220 |
Why?
|
| Brain Injuries | 1 | 2007 | 129 | 0.220 |
Why?
|
| Facial Expression | 2 | 2016 | 25 | 0.210 |
Why?
|
| Prefrontal Cortex | 4 | 2010 | 164 | 0.190 |
Why?
|
| Cold Temperature | 1 | 2002 | 40 | 0.190 |
Why?
|
| Cognition | 4 | 2014 | 473 | 0.180 |
Why?
|
| Cerebrovascular Circulation | 3 | 2011 | 70 | 0.180 |
Why?
|
| Hot Temperature | 1 | 2002 | 141 | 0.180 |
Why?
|
| Smoking | 3 | 2016 | 1024 | 0.170 |
Why?
|
| Baroreflex | 2 | 2015 | 10 | 0.170 |
Why?
|
| Depressive Disorder | 2 | 2013 | 187 | 0.160 |
Why?
|
| Regression Analysis | 3 | 2018 | 490 | 0.160 |
Why?
|
| Arousal | 2 | 2011 | 95 | 0.160 |
Why?
|
| Sympathetic Nervous System | 2 | 2011 | 57 | 0.140 |
Why?
|
| Psychophysiology | 1 | 2018 | 14 | 0.140 |
Why?
|
| Fourier Analysis | 5 | 2005 | 45 | 0.140 |
Why?
|
| Hypertension | 5 | 2011 | 835 | 0.140 |
Why?
|
| Serotonin | 2 | 2015 | 123 | 0.140 |
Why?
|
| Anger | 3 | 2007 | 27 | 0.130 |
Why?
|
| Stereotyping | 1 | 2017 | 45 | 0.130 |
Why?
|
| Placebo Effect | 2 | 2015 | 14 | 0.130 |
Why?
|
| Designer Drugs | 1 | 2015 | 2 | 0.120 |
Why?
|
| Dextroamphetamine | 1 | 2015 | 9 | 0.120 |
Why?
|
| Positron-Emission Tomography | 3 | 2011 | 93 | 0.120 |
Why?
|
| Saliva | 3 | 2014 | 119 | 0.120 |
Why?
|
| Circadian Rhythm | 2 | 2015 | 236 | 0.120 |
Why?
|
| Chronic Disease | 1 | 2018 | 549 | 0.110 |
Why?
|
| Spinal Cord Injuries | 1 | 2015 | 69 | 0.110 |
Why?
|
| Piperazines | 1 | 2015 | 120 | 0.110 |
Why?
|
| Reference Values | 4 | 2009 | 211 | 0.110 |
Why?
|
| Electrocardiography, Ambulatory | 3 | 2005 | 13 | 0.110 |
Why?
|
| Psychomotor Performance | 1 | 2015 | 159 | 0.110 |
Why?
|
| Recovery of Function | 1 | 2015 | 107 | 0.110 |
Why?
|
| Posture | 1 | 2014 | 61 | 0.110 |
Why?
|
| Sex Characteristics | 3 | 2011 | 258 | 0.110 |
Why?
|
| Algorithms | 4 | 2005 | 509 | 0.100 |
Why?
|
| Brain | 3 | 2011 | 1472 | 0.100 |
Why?
|
| Computer Simulation | 2 | 2007 | 408 | 0.100 |
Why?
|
| Central Nervous System Stimulants | 1 | 2015 | 180 | 0.100 |
Why?
|
| Hand Strength | 2 | 2011 | 40 | 0.100 |
Why?
|
| Parasympathetic Nervous System | 2 | 2011 | 8 | 0.100 |
Why?
|
| Histamine Antagonists | 1 | 2013 | 6 | 0.100 |
Why?
|
| Models, Statistical | 4 | 2010 | 195 | 0.100 |
Why?
|
| Aged | 11 | 2014 | 8214 | 0.100 |
Why?
|
| Face | 1 | 2013 | 40 | 0.100 |
Why?
|
| Drug Eruptions | 1 | 2013 | 8 | 0.100 |
Why?
|
| Personality | 1 | 2013 | 55 | 0.100 |
Why?
|
| Robotics | 1 | 2013 | 43 | 0.100 |
Why?
|
| Histamine | 1 | 2013 | 19 | 0.100 |
Why?
|
| Brain Diseases | 2 | 2010 | 31 | 0.100 |
Why?
|
| Data Interpretation, Statistical | 3 | 2010 | 125 | 0.090 |
Why?
|
| Age Factors | 5 | 2008 | 1154 | 0.090 |
Why?
|
| Perception | 1 | 2013 | 215 | 0.090 |
Why?
|
| Culture | 1 | 2013 | 172 | 0.090 |
Why?
|
| Statistics as Topic | 4 | 2010 | 123 | 0.090 |
Why?
|
| Health Status Disparities | 1 | 2017 | 719 | 0.080 |
Why?
|
| Environment, Controlled | 1 | 2010 | 7 | 0.080 |
Why?
|
| Pulmonary Disease, Chronic Obstructive | 1 | 2013 | 167 | 0.080 |
Why?
|
| Occupational Health | 1 | 2010 | 32 | 0.080 |
Why?
|
| Functional Laterality | 3 | 2010 | 89 | 0.080 |
Why?
|
| Fatigue | 1 | 2011 | 100 | 0.080 |
Why?
|
| Child | 1 | 2018 | 3443 | 0.080 |
Why?
|
| Carcinoma | 1 | 2011 | 108 | 0.080 |
Why?
|
| Anxiety Disorders | 1 | 2013 | 322 | 0.080 |
Why?
|
| Survivors | 1 | 2011 | 152 | 0.080 |
Why?
|
| Workplace | 1 | 2010 | 92 | 0.080 |
Why?
|
| Vascular Resistance | 2 | 2007 | 36 | 0.080 |
Why?
|
| Phobic Disorders | 1 | 2009 | 25 | 0.080 |
Why?
|
| Sensitivity and Specificity | 4 | 2004 | 611 | 0.070 |
Why?
|
| Stress, Physiological | 1 | 2010 | 172 | 0.070 |
Why?
|
| Hypnotics and Sedatives | 1 | 2008 | 27 | 0.070 |
Why?
|
| Mental Recall | 2 | 2009 | 84 | 0.070 |
Why?
|
| Exercise | 1 | 2014 | 692 | 0.070 |
Why?
|
| Affect | 2 | 2014 | 180 | 0.070 |
Why?
|
| Suicide, Attempted | 1 | 2009 | 108 | 0.070 |
Why?
|
| Attention | 3 | 2009 | 174 | 0.070 |
Why?
|
| Suicide | 1 | 2009 | 140 | 0.070 |
Why?
|
| Cardiovascular Diseases | 1 | 2015 | 749 | 0.070 |
Why?
|
| Smoking Cessation | 1 | 2014 | 590 | 0.070 |
Why?
|
| Expressed Emotion | 1 | 2007 | 9 | 0.070 |
Why?
|
| Statistical Distributions | 1 | 2007 | 3 | 0.060 |
Why?
|
| Least-Squares Analysis | 1 | 2007 | 45 | 0.060 |
Why?
|
| Tai Ji | 1 | 2006 | 4 | 0.060 |
Why?
|
| Analysis of Variance | 4 | 2010 | 575 | 0.060 |
Why?
|
| Vascular Capacitance | 1 | 2006 | 1 | 0.060 |
Why?
|
| Elasticity | 1 | 2006 | 53 | 0.060 |
Why?
|
| Pituitary-Adrenal System | 1 | 2005 | 41 | 0.060 |
Why?
|
| Blood Pressure Monitoring, Ambulatory | 2 | 2004 | 65 | 0.060 |
Why?
|
| Hypothalamo-Hypophyseal System | 1 | 2005 | 55 | 0.060 |
Why?
|
| Statistics, Nonparametric | 2 | 2015 | 113 | 0.060 |
Why?
|
| Pilot Projects | 4 | 2011 | 760 | 0.060 |
Why?
|
| Double-Blind Method | 2 | 2015 | 317 | 0.050 |
Why?
|
| Adaptation, Psychological | 2 | 2007 | 420 | 0.050 |
Why?
|
| Peptidyl-Dipeptidase A | 1 | 2003 | 35 | 0.050 |
Why?
|
| Affective Symptoms | 1 | 2004 | 63 | 0.050 |
Why?
|
| Cues | 2 | 2016 | 81 | 0.050 |
Why?
|
| Cluster Analysis | 1 | 2004 | 207 | 0.050 |
Why?
|
| Polymorphism, Genetic | 1 | 2003 | 201 | 0.050 |
Why?
|
| Injections, Intra-Arterial | 1 | 2002 | 5 | 0.050 |
Why?
|
| Educational Status | 1 | 2004 | 339 | 0.050 |
Why?
|
| Respiration | 1 | 2002 | 56 | 0.050 |
Why?
|
| Carotid Artery, Internal | 1 | 2002 | 8 | 0.050 |
Why?
|
| Aggression | 1 | 2003 | 102 | 0.050 |
Why?
|
| Alcoholism | 1 | 2005 | 305 | 0.050 |
Why?
|
| Movement | 1 | 2003 | 119 | 0.050 |
Why?
|
| Universities | 2 | 2002 | 559 | 0.040 |
Why?
|
| Environment | 1 | 2003 | 149 | 0.040 |
Why?
|
| Aged, 80 and over | 4 | 2011 | 2853 | 0.040 |
Why?
|
| Behavior Therapy | 1 | 2003 | 180 | 0.040 |
Why?
|
| Risk Factors | 4 | 2015 | 3994 | 0.040 |
Why?
|
| Alcohol Drinking | 1 | 2005 | 609 | 0.040 |
Why?
|
| Students | 2 | 2002 | 626 | 0.040 |
Why?
|
| Breast Neoplasms | 1 | 2011 | 1723 | 0.040 |
Why?
|
| Brain Mapping | 2 | 2010 | 137 | 0.040 |
Why?
|
| Nicotine | 1 | 2002 | 302 | 0.040 |
Why?
|
| Neuropsychological Tests | 2 | 2010 | 284 | 0.040 |
Why?
|
| Hemodynamics | 2 | 2011 | 100 | 0.030 |
Why?
|
| Amygdala | 2 | 2011 | 125 | 0.030 |
Why?
|
| Time Factors | 1 | 2002 | 1857 | 0.030 |
Why?
|
| Event-Related Potentials, P300 | 1 | 2015 | 5 | 0.030 |
Why?
|
| Longitudinal Studies | 2 | 2009 | 1063 | 0.030 |
Why?
|
| Systole | 1 | 2015 | 67 | 0.030 |
Why?
|
| Diastole | 1 | 2015 | 47 | 0.030 |
Why?
|
| Reproducibility of Results | 3 | 2004 | 1081 | 0.030 |
Why?
|
| Drug Synergism | 1 | 2015 | 195 | 0.030 |
Why?
|
| Reaction Time | 1 | 2015 | 157 | 0.030 |
Why?
|
| Body Mass Index | 2 | 2011 | 925 | 0.030 |
Why?
|
| United States | 1 | 2006 | 5205 | 0.030 |
Why?
|
| Administration, Intranasal | 1 | 2015 | 89 | 0.030 |
Why?
|
| New Zealand | 1 | 2014 | 32 | 0.030 |
Why?
|
| Cross-Over Studies | 1 | 2014 | 115 | 0.030 |
Why?
|
| Smoke | 1 | 2014 | 42 | 0.030 |
Why?
|
| Socioeconomic Factors | 2 | 2011 | 1234 | 0.030 |
Why?
|
| Adaptation, Physiological | 2 | 2007 | 143 | 0.030 |
Why?
|
| Dopamine | 1 | 2015 | 275 | 0.030 |
Why?
|
| Self Concept | 1 | 2014 | 171 | 0.020 |
Why?
|
| Vital Capacity | 1 | 2013 | 44 | 0.020 |
Why?
|
| Administration, Topical | 1 | 2013 | 39 | 0.020 |
Why?
|
| Forced Expiratory Volume | 1 | 2013 | 75 | 0.020 |
Why?
|
| Psychological Tests | 1 | 2011 | 56 | 0.020 |
Why?
|
| Monitoring, Physiologic | 1 | 2011 | 39 | 0.020 |
Why?
|
| Oxygen Radioisotopes | 1 | 2011 | 2 | 0.020 |
Why?
|
| Gyrus Cinguli | 1 | 2011 | 31 | 0.020 |
Why?
|
| Cross-Sectional Studies | 2 | 2009 | 3156 | 0.020 |
Why?
|
| Frontal Lobe | 1 | 2011 | 58 | 0.020 |
Why?
|
| Norepinephrine | 1 | 2011 | 97 | 0.020 |
Why?
|
| Colorado | 1 | 2010 | 16 | 0.020 |
Why?
|
| Comorbidity | 1 | 2013 | 737 | 0.020 |
Why?
|
| Motivation | 1 | 2014 | 513 | 0.020 |
Why?
|
| Verbal Learning | 1 | 2009 | 18 | 0.020 |
Why?
|
| Exercise Test | 1 | 2010 | 74 | 0.020 |
Why?
|
| Baltimore | 1 | 2009 | 58 | 0.020 |
Why?
|
| Executive Function | 1 | 2009 | 59 | 0.020 |
Why?
|
| Research Design | 1 | 2011 | 385 | 0.020 |
Why?
|
| Anticonvulsants | 1 | 2008 | 40 | 0.020 |
Why?
|
| Tomography, X-Ray Computed | 1 | 2010 | 245 | 0.020 |
Why?
|
| Spectrum Analysis | 1 | 2008 | 61 | 0.020 |
Why?
|
| Epilepsy | 1 | 2008 | 59 | 0.020 |
Why?
|
| Psychometrics | 1 | 2009 | 358 | 0.020 |
Why?
|
| Cardiography, Impedance | 1 | 2006 | 4 | 0.020 |
Why?
|
| Cross-Cultural Comparison | 1 | 2007 | 111 | 0.020 |
Why?
|
| Delivery of Health Care | 1 | 2009 | 310 | 0.020 |
Why?
|
| Magnetic Resonance Imaging | 1 | 2010 | 587 | 0.020 |
Why?
|
| Feedback | 1 | 2005 | 56 | 0.010 |
Why?
|
| Neural Inhibition | 1 | 2005 | 48 | 0.010 |
Why?
|
| Personality Tests | 1 | 2004 | 7 | 0.010 |
Why?
|
| Oxygen Consumption | 1 | 2004 | 110 | 0.010 |
Why?
|
| Physical Fitness | 1 | 2004 | 90 | 0.010 |
Why?
|
| Occupations | 1 | 2004 | 27 | 0.010 |
Why?
|
| Speech | 1 | 2004 | 16 | 0.010 |
Why?
|
| Pattern Recognition, Automated | 1 | 2004 | 32 | 0.010 |
Why?
|
| Adrenergic beta-Antagonists | 1 | 2003 | 54 | 0.010 |
Why?
|
| North Carolina | 1 | 2004 | 127 | 0.010 |
Why?
|
| Models, Psychological | 1 | 2004 | 140 | 0.010 |
Why?
|
| Facial Muscles | 1 | 2003 | 7 | 0.010 |
Why?
|
| Twin Studies as Topic | 1 | 2003 | 3 | 0.010 |
Why?
|
| Monitoring, Ambulatory | 1 | 2003 | 13 | 0.010 |
Why?
|
| Physical Stimulation | 1 | 2003 | 27 | 0.010 |
Why?
|
| Acceleration | 1 | 2003 | 3 | 0.010 |
Why?
|
| Restraint, Physical | 1 | 2003 | 22 | 0.010 |
Why?
|
| Transducers | 1 | 2003 | 14 | 0.010 |
Why?
|
| Respiratory Mechanics | 1 | 2003 | 27 | 0.010 |
Why?
|
| Electromyography | 1 | 2003 | 69 | 0.010 |
Why?
|
| Income | 1 | 2004 | 160 | 0.010 |
Why?
|
| Sample Size | 1 | 2002 | 28 | 0.010 |
Why?
|
| Drug Tolerance | 1 | 2002 | 26 | 0.010 |
Why?
|
| Administration, Inhalation | 1 | 2002 | 92 | 0.010 |
Why?
|
| Dogs | 1 | 2003 | 204 | 0.010 |
Why?
|
| Homeostasis | 1 | 2003 | 192 | 0.010 |
Why?
|
| Genotype | 1 | 2003 | 800 | 0.010 |
Why?
|
| Antihypertensive Agents | 1 | 2003 | 287 | 0.010 |
Why?
|
| Dose-Response Relationship, Drug | 1 | 2002 | 1124 | 0.010 |
Why?
|
| Models, Biological | 1 | 2002 | 712 | 0.010 |
Why?
|
| Animals | 1 | 2003 | 16992 | 0.000 |
Why?
|